Chen et al. proposed the use of novel nano-formulation approaches to target shipping and delivery of these phytonutrients. The cumulative transportation and bioavailability of nano-EGCG was about twice of free EGCG, along with the dose advantage of nano-EGCG to induce apoptosis in prostate cancer cells was more than 10 times (178). However , you